Clinical trials: Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy
Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy, High-grade Serous Ovarian Carcinoma
Prognostic Value of KELIM Score and Inflammatory Markers in Ovarian Cancer
This is a retrospective observational study to evaluate the integrative prognostic value of inflammatory markers, specifically the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), alongside the CA-125…
- Trial name
- NCT07678008
- Where
- Egypt
- Volunteers
- 80 people
- Sponsor
- Aya Ahmed Nasser
Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy
LYmphadenectomy After NeoAdjuvant Chemotherapy
The purpose of this study is to determine the role of lymphadenectomy in advenced ovarian cancer patients at the time of interval debulking surgery after neoadjuvant chemiotherapy.
- Trial name
- LYANA (NCT01724944)
- Testing
- Systematic pelvic and aortic lymphadenectomy
- Where
- Italy
- Volunteers
- 65 people
- Sponsor
- Catholic University of the Sacred Heart